Financial Toxicity and Quality of Life in Patients With TGCT

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

February 4, 2025

Study Completion Date

February 4, 2025

Conditions
Testicular Neoplasm
Interventions
OTHER

Comprehensive Score for financial toxicity (COST)

Measure indirect and direct health care cost that burden patients and their loved ones.

OTHER

Functional Assessment of Cancer Therapy: General (FACT-G)

General quality of life instrument

OTHER

EORTC QLQ C-30

Assess quality of life in cancer patients

OTHER

EORTC QLQ-TC26.

To measure disease and treatment related quality of life issues relevant to testicular cancer patients that were not explored in the QLQ-C30 questionnaire.

Trial Locations (1)

78229

Mays Cancer Center, San Antonio

All Listed Sponsors
lead

The University of Texas Health Science Center at San Antonio

OTHER